JHIU
ABMD

Janus Henderson Investors US’s Abiomed Inc ABMD Stock Holding History

Janus Henderson Investors US’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$11.1M Sell
88,968
-47,411
-35% -$5.5M 0.01% 690
2016
Q4 		$15.4M Buy
136,379
+30,692
+29% +$3.56M 0.01% 663
2016
Q3 		$13.6M Buy
105,687
+101,284
+2,300% +$12.1M 0.01% 653
2016
Q2 		$481K Buy
+4,403
New +$438K ﹤0.01% 1097

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Janus Henderson Investors US's ABMD Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Abiomed Inc (ABMD) stake by 35% in Q1 2017, selling an estimated $5.5M and leaving 88,968 shares worth $11.1M. The position accounts for 0.01% of the portfolio, ranked #690.

Janus Henderson Investors US first reported a position in ABMD in Q2 2016 and has held it in 4 quarters since. The position peaked at $15.4M in Q4 2016. 287 funds tracked by Wall St. Rank hold ABMD as of Q1 2017.

  • Janus Henderson Investors US held 88,968 shares of Abiomed Inc worth $11.1M as of Q1 2017.
  • Janus Henderson Investors US sold 47,411 Abiomed Inc shares in Q1 2017, an estimated $5.5M.
  • Abiomed Inc made up 0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #690 holding.
  • Janus Henderson Investors US first reported a position in Abiomed Inc in Q2 2016 and has held it in 4 quarters since.
  • Janus Henderson Investors US's Abiomed Inc position peaked at $15.4M in Q4 2016.
  • 287 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.